16-78949740-A-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_016373.4(WWOX):​c.1057-261868A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.299 in 152,106 control chromosomes in the GnomAD database, including 7,806 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.30 ( 7806 hom., cov: 32)

Consequence

WWOX
NM_016373.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.09

Publications

3 publications found
Variant links:
Genes affected
WWOX (HGNC:12799): (WW domain containing oxidoreductase) This gene encodes a member of the short-chain dehydrogenases/reductases (SDR) protein family. This gene spans the FRA16D common chromosomal fragile site and appears to function as a tumor suppressor gene. Expression of the encoded protein is able to induce apoptosis, while defects in this gene are associated with multiple types of cancer. Disruption of this gene is also associated with autosomal recessive spinocerebellar ataxia 12. Disruption of a similar gene in mouse results in impaired steroidogenesis, additionally suggesting a metabolic function for the protein. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
WWOX Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal recessive spinocerebellar ataxia 12
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P
  • developmental and epileptic encephalopathy, 28
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • 46,XY partial gonadal dysgenesis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.379 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_016373.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
WWOX
NM_016373.4
MANE Select
c.1057-261868A>T
intron
N/ANP_057457.1Q9NZC7-1
WWOX
NM_001291997.2
c.718-261868A>T
intron
N/ANP_001278926.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
WWOX
ENST00000566780.6
TSL:1 MANE Select
c.1057-261868A>T
intron
N/AENSP00000457230.1Q9NZC7-1
WWOX
ENST00000402655.6
TSL:1
c.410-261868A>T
intron
N/AENSP00000384238.2Q9NZC7-6
WWOX
ENST00000406884.6
TSL:1
c.517-261868A>T
intron
N/AENSP00000384495.2Q9NZC7-5

Frequencies

GnomAD3 genomes
AF:
0.299
AC:
45445
AN:
151988
Hom.:
7806
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.124
Gnomad AMI
AF:
0.367
Gnomad AMR
AF:
0.312
Gnomad ASJ
AF:
0.426
Gnomad EAS
AF:
0.325
Gnomad SAS
AF:
0.319
Gnomad FIN
AF:
0.349
Gnomad MID
AF:
0.341
Gnomad NFE
AF:
0.383
Gnomad OTH
AF:
0.324
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.299
AC:
45459
AN:
152106
Hom.:
7806
Cov.:
32
AF XY:
0.299
AC XY:
22251
AN XY:
74354
show subpopulations
African (AFR)
AF:
0.124
AC:
5152
AN:
41530
American (AMR)
AF:
0.313
AC:
4777
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.426
AC:
1476
AN:
3468
East Asian (EAS)
AF:
0.325
AC:
1677
AN:
5156
South Asian (SAS)
AF:
0.320
AC:
1541
AN:
4820
European-Finnish (FIN)
AF:
0.349
AC:
3691
AN:
10570
Middle Eastern (MID)
AF:
0.336
AC:
98
AN:
292
European-Non Finnish (NFE)
AF:
0.383
AC:
26030
AN:
67968
Other (OTH)
AF:
0.324
AC:
683
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1545
3091
4636
6182
7727
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
472
944
1416
1888
2360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.214
Hom.:
543
Bravo
AF:
0.289
Asia WGS
AF:
0.320
AC:
1112
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.086
DANN
Benign
0.64
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11642227; hg19: chr16-78983637; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.